Sanovas: Disrupting The MIS Market
This article was originally published in Start Up
Executive Summary
There’s tremendous potential for growth in minimally invasive surgeries, but successfully tapping into that market requires broad expertise. In an exclusive interview, Larry Gerrans, co-founder and CEO of medical device developer Sanovas, talks about his formulated approach to developing technologies, launching new companies, and disrupting the status quo.
You may also be interested in...
MIS 2014, Part 2: Opportunities And Challenges
The increasing prevalence of MIS and the opportunity for greater MIS penetration in existing procedures translate into significant growth potential for the MIS products market in the years ahead. Despite some challenges, device manufacturers are driving growth in the market by targeting key procedures and geographies with new robotic surgery systems and robotic-like technologies designed to enable more complex procedures to be performed via an MIS approach.
MIS Trends 2014: Improving Visualization
Innovation is driving healthy growth in the multibillion-dollar market for minimally invasive surgical products as manufacturers develop new laparoscopic visualization systems and advanced surgical tools with robotic-like features designed to enable more complex procedures to be performed via a minimally invasive approach.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.